SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001689813-19-000089
Filing Date
2019-11-01
Accepted
2019-11-01 17:17:03
Documents
65
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q bhvn-20190930.htm   iXBRL 10-Q 1448530
2 EXHIBIT 31.1 a2019q3bhvn10-qexh311.htm EX-31.1 16397
3 EXHIBIT 31.2 a2019q3bhvn10-qexh312.htm EX-31.2 16368
4 EXHIBIT 32.1 a2019q3bhvn10-qexh321.htm EX-32.1 10658
  Complete submission text file 0001689813-19-000089.txt   6176800

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT bhvn-20190930.xsd EX-101.SCH 50084
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT bhvn-20190930_cal.xml EX-101.CAL 61973
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT bhvn-20190930_def.xml EX-101.DEF 184564
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT bhvn-20190930_lab.xml EX-101.LAB 476638
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT bhvn-20190930_pre.xml EX-101.PRE 302613
29 EXTRACTED XBRL INSTANCE DOCUMENT bhvn-20190930_htm.xml XML 1144321
Mailing Address 215 CHURCH STREET NEW HAVEN CT 06510
Business Address 215 CHURCH STREET NEW HAVEN CT 06510 203-404-0410
Biohaven Pharmaceutical Holding Co Ltd. (Filer) CIK: 0001689813 (see all company filings)

IRS No.: 000000000 | State of Incorp.: D8 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38080 | Film No.: 191187638
SIC: 2834 Pharmaceutical Preparations